课题基金 / 基金详情

Detecting invading glioma cells through in vivo molecular imaging of the cell sur

Detecting invading glioma cells through in vivo molecular imaging of the cell sur
通过细胞表面的体内分子成像检测入侵的神经胶质瘤细胞
批准号:
8449143
负责人:
SUSANN M BRADY-KALNAY
金额:
$35.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2014-03-31

项目摘要

项目成果

SUSANN M BRADY-KALNAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We identified a unique marker of invading glioma cells that arises from PTP¿ cleavage. We developed a specific molecular imaging probe that binds to the cleaved PTP¿ fragment and recognizes glioblastomas. Therefore, we will test the hypothesis that this probe marks high-grade human gliomas and defines the invading tumor margin. We will explore its utility as a diagnostic molecular imaging agent and as a therapeutic. Primary brain tumors commonly arise from supporting glial cells within the central nervous system. These tumors are called gliomas and typically disperse widely throughout the brain making complete surgical resection impossible. The invasive properties of gliomas lead to difficulties in determining the extent of invasion and make this disease virtually incurable with a mean survival of approximately one year. PTP¿ is a cell surface receptor protein tyrosine phosphatase (RPTP) and a cell adhesion molecule whose expression is down-regulated in human gliomas. Very recent data suggests that during PTP¿ down-regulation, the protein is proteolyzed and a small fragment remains associated with the glioblastoma cells. Here we describe studies that utilize a unique robust molecular imaging probe for the PTP¿ fragment and test its effectiveness in vivo. Our hypothesis is that the probe will detect the migrating and invading glioblastomas at the cellular level and can eventually be used in human patients to image the tumors with magnetic resonance imaging (MRI). Identification of key molecular targets such as PTP¿ will allow development of novel strategies to diagnose, image and eventually treat gliomas. It is envisioned that this probe could also be utilized during surgery to guide neurosurgery of the tumors enabling more complete and precise tumor resection, which will enhance patient survival. Aim 1: Determine the extent of association of the cleaved fragment of PTP¿ with invasiveness of human gliomas of various types and grades. Aim 2: Assess the utility of peptide probes to monitor migrating glioma cells in an ex vivo brain slice invasion assay. Aim 3: Examine the utility of the probe to detect tumors and migrating glioma cells in vivo in heterotopic and orthotopic human brain tumor models in rodents.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jcb.24824
发表时间: 2014-09
期刊: Journal of cellular biochemistry
影响因子: 4
作者: [Phillips-Mason PJ, Craig SE, Brady-Kalnay SM]
通讯作者: Brady-Kalnay SM
DOI: 10.1016/j.semcdb.2014.09.004
发表时间: 2015-01
期刊: Seminars in cell & developmental biology
影响因子: 7.3
作者: [Craig SE, Brady-Kalnay SM]
通讯作者: Brady-Kalnay SM
Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu
  • 批准号:
    10594178
  • 项目类别:
  • 资助金额:
    $66.81万
  • 财政年份:
    2022
  • 负责人:
    SUSANN M BRADY-KALNAY
  • 依托单位:
Whole-Organism, Real-time Decision-enabled 3D Tissue Imaging and Recovery for Molecular Analysis
  • 批准号:
    10546698
  • 项目类别:
  • 资助金额:
    $22.42万
  • 财政年份:
    2022
  • 负责人:
    SUSANN M BRADY-KALNAY
  • 依托单位:
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
  • 批准号:
    9363032
  • 项目类别:
  • 资助金额:
    $66.29万
  • 财政年份:
    2017
  • 负责人:
    SUSANN M BRADY-KALNAY
  • 依托单位:
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
  • 批准号:
    9927600
  • 项目类别:
  • 资助金额:
    $68.24万
  • 财政年份:
    2017
  • 负责人:
    SUSANN M BRADY-KALNAY
  • 依托单位:
海外基金